UBX: Rentabilitas operasi Unity Biotechnology, Inc.

Logo korporat perusahaan Unity Bio (UBX)

Unity Biotechnology develops senolytics to combat aging, leveraging robust patent protection and a debt-free balance sheet. Its innovative platform for clearing senescent cells from the body promises a monopoly status for the therapy. An operational profitability assessment by GURU.Markets produces this chart, where 0.00 characterizes this specific valuation parameter. The company is currently seeking strategic R&D partners due to limited liquidity.

Unity Biotechnology, Inc. (UBX): Rentabilitas operasi saka 04.07.2022 nganti 19.07.2025

Ringkesan rincian data analitis Unity Biotechnology, Inc. (UBX)

Analisis fundamental perusahaan:Unity Biotechnology Inc.
Produk dadi unitybiotechnology.com

Operating margin measures the share of profit from core operations relative to total revenue, demonstrating cost management efficiency before accounting for taxes and interest obligations. For Unity Biotechnology (UBX), which lacks commercial products and relies on clinical trials to compete, the operating profitability trend serves as an indicator of the capital burn rate while protecting patents.

Pesaing utama

Margin dodolan operasi TEM|QGEN - Tingkat bathi adhedhasar bathi operasi|Margin operasi IONS|RGEN - Rentabilitas dodolan operasi|Rentabilitas operasi Avidity RNA|Margin operasi CRISPR Therapeutics Corp CRSP|GeneDx Corp - Margin operasi|Ultragenyx Pharma (RARE) - Margin dodolan operasi|beamtx.com (BEAM) - Rentabilitas operasi|SRPT: Rasio bathi operasi|Margin dodolan operasi TWST|TXG - Tingkat bathi adhedhasar bathi operasi|Margin operasi NTLA|Rentabilitas kegiatan operasi Stoke Therapeutics|Rentabilitas operasi BioLife Solutions BLFS|Wave Life Sciences (WVE) - Rentabilitas dodolan operasi|Maze Therapeutics, Inc. - Margin operasi|Rentabilitas kegiatan operasi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Rentabilitas operasi|TSHA: Rasio bathi operasi|Rentabilitas operasi uniQure Pharma|MGTX - Tingkat bathi adhedhasar bathi operasi|Margin operasi RGNX|Rentabilitas operasi SLDB (Solid Biosciences)|Ocugen Corp - Margin dodolan operasi|PACB: Rentabilitas dodolan miturut bathi operasi|benitec.com - Margin operasi|DSGN - Margin operasi|RCKT: Margin operasi|FDMT (4D Molecular Therapeutics Inc) - Rentabilitas operasi|Margin dodolan operasi LXEO|Rentabilitas operasi KRRO|Margin operasi EDIT|SLN - Rentabilitas dodolan operasi|Margin operasi PRQR (ProQR)|CDXS - Margin dodolan operasi|Sangamo Therapeutics Inc. - Margin operasi|NAUT - Margin operasi|MGX: Margin operasi|Margin dodolan operasi Precision BioSciences, Inc.|GBIO (Generation Bio) - Margin operasi|Boundless Bio Inc. (BOLD) - Rentabilitas kegiatan operasi|Margin dodolan operasi XCUR (exicuretx.com)|Imunon Inc - Rentabilitas dodolan miturut bathi operasi|Margin operasi PHIO (Phio Pharmaceuticals Corp)|Tingkat bathi operasi MBIO|RNAZ - Rentabilitas operasi|Tingkat bathi operasi BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Rentabilitas operasi|Bluebird Bio - Tingkat bathi operasi|IPA (ImmunoPrecise Antibodies Ltd) - Margin operasi|Rentabilitas dodolan operasi Omega Therapeutics, Inc. OMGA|Margin operasi OMIC|RGLS (Regulus Therapeutics Inc.) - Tingkat bathi operasi|Margin operasi SYRS (Syros Pharmaceuticals Inc.)|Rasio bathi operasi TBIO (Codex DNA)|TCON - Rentabilitas operasi